Press Release

Global Lung Cancer Surgical Treatment Market Perspective with Study of Key Players & Revenue to Steady Growth Forecast To 2020

Fortune Business Insights projects the rising prevalence of lung cancer on a global basis to boost the global lung cancer surgical treatment market size, in their new report titled, “Lung Cancer Surgical Treatment Market Size, Share and Global Trend by Surgical Procedure (Pneumonectomy, Lobectomy, Segmentectomy, Sleeve Resection, Others), By End User (Hospitals, Clinics, Others) and Geography Forecast till 2026.” According to the American Cancer Society, an estimated 228,150 new lung cancer cases to be reported in 2019 in the U.S. The report by Fortune Business Insights foresees lobectomy in the surgical procedure segment to lead the market and remain dominant through the forecast period. This is due to the benefits of lobectomy and convenience and minimal side effects associated with this process even after the affected lobe is removed from the lung. Such factors are likely to bode well for the segment and help it emerge as the dominant one in terms of surgical procedures.

 

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/lung-cancer-surgical-treatment-market-100851

 

 

Leading Players operating in the Lung Cancer Surgical Treatment Market are:

 

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

 

  • Covidien PLC,
  • Ethicon US LLC,
  • AngioDynamics Inc.,
  • Intuitive Surgical Inc.,
  • Accuray Inc.,
  • Teleflex Inc.,
  • Scanlan International Inc.,
  • Olympus Corporation,
  • KARL STORZ GmbH,
  • Ackermann Instrumente GmbH,
  • Trokamed GmbH

Market Segmentation:

By Surgical Procedure

  • Pneumonectomy
  • Lobectomy
  • Segmentectomy
  • Sleeve Resection
  • Others

By End-User

  • Hospitals
  • Clinics
  • Others

By Geography

 

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)

 

 

Reasons to Purchase this Report:

 

  • Comprehensive analysis of the Lung Cancer Surgical Treatment Market growth drivers, obstacles, opportunities, and other related challenges.
  • Tracks the developments, such as new product launches, agreements, mergers and acquisitions, geographical expansions, and joint ventures.
  • Identifies market restraints and boosters.
  • Identifies all the possible segments present in the market to aid organizations in strategic business planning.

More Trending Topics From Fortune Business [email protected]

Population Health Management Market size

Legionella Testing Market Share

Legionella Testing Market size

Legionella Testing Market Share

Legionella Testing Market size

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close